Otsuka Holdings Co., Ltd.TSE: 4578

Otsuka Reports Positive Phase 3 VISIONARY Two-Year eGFR Results for VOYXACT in IgAN

Jul 1, 2026 at 11:30 PM UTC · Issued by Otsuka Holdings Co., Ltd. via TDnet

Otsuka Holdings Co., Ltd. (4578) Press Release

View Attachment

Earlier from Otsuka

Otsuka Presents Positive Interim Phase 3 VISIONARY eGFR Data Showing VOYXACT Preserved Kidney Function Over 12 Months in IgA NephropathyJun 4

All Otsuka news releases